These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1091001)

  • 21. Effects of colestipol hydrochloride on cholesterol and bile acids absorption in the rat intestinal tract.
    Fujihashi T; Munekiyo K; Meshi T
    J Pharmacobiodyn; 1981 Aug; 4(8):552-8. PubMed ID: 7299619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary.
    Cooper EE; Michel AM
    Adv Exp Med Biol; 1977; 82():191-4. PubMed ID: 920358
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

  • 24. Focus on fenofibrate.
    Brown WV
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
    [No Abstract]   [Full Text] [Related]  

  • 25. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
    Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
    Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choosing the right lipid-regulating agent. A guide to selection.
    Farmer JA; Gotto AM
    Drugs; 1996 Nov; 52(5):649-61. PubMed ID: 9118815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
    Crouse JR
    Am J Med; 1987 Aug; 83(2):243-8. PubMed ID: 3618626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
    Glueck CJ; Fallat RW; Mellies M; Tsang RC
    Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of colestipol hydrochloride (U-26,597A) on serum and fecal lipids in dogs.
    Parkinson TM; Schneider JC; Phillips WA
    Atherosclerosis; 1973; 17(2):167-79. PubMed ID: 4709118
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of halofenate on serum uric acid.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP
    Clin Pharmacol Ther; 1973; 14(3):371-3. PubMed ID: 4572799
    [No Abstract]   [Full Text] [Related]  

  • 33. The acceptability of resin therapy to patients attending a hospital lipid clinic.
    Iversen SA; Davidson D; Davidson C
    Br J Clin Pharmacol; 1995 Jul; 40(1):92-4. PubMed ID: 8527276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.
    Molcányiová A; Stancáková A; Javorský M; Tkác I
    Pharmacol Res; 2006 Sep; 54(3):203-7. PubMed ID: 16737822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colestipol hydrochloride for treatment of hypercholesterolemia in a family practice: five-year study.
    Ruoff G
    J Am Geriatr Soc; 1978 Mar; 26(3):121-6. PubMed ID: 624819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
    Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term therapy of hypercholesteremia in diabetics with colestipol].
    Düntsch G
    Fortschr Med; 1981 Jan; 99(3):73-5. PubMed ID: 6781999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of clinofibrate, a new hypolipidemic agent, on biliary and serum lipids in patients with hyperlipidemia.
    Takeuchi N; Kukita H; Kajiyama G; Fujiyama M; Ishikawa K; Miki H; Mishima T; Murata K; Asano T
    Atherosclerosis; 1982 Apr; 42(2-3):129-39. PubMed ID: 7073798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and future therapeutic approaches to hyperlipidemia.
    Farmer JA; Gotto AM
    Adv Pharmacol; 1996; 35():79-114. PubMed ID: 8920205
    [No Abstract]   [Full Text] [Related]  

  • 40. Colesevelam hydrochloride.
    Steinmetz KL
    Am J Health Syst Pharm; 2002 May; 59(10):932-9. PubMed ID: 12040732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.